scholarly journals 329 Patient selection and learning curve influence the results of transapical aortic valve implantation

2010 ◽  
Vol 2 (1) ◽  
pp. 108
Author(s):  
Patrick Nataf ◽  
Nawwar Al-Attar ◽  
Costin Radu ◽  
Dominique Himbert ◽  
Richard Raffoul ◽  
...  
2020 ◽  
Vol 36 (2) ◽  
pp. 152-161
Author(s):  
Anne-Pauline Thivilliers ◽  
Rémi Ladarré ◽  
Océane Merabti ◽  
Caroline François ◽  
Sarah Fontenay ◽  
...  

BackgroundTranscatheter aortic-valve implantation (TAVI) has become an essential alternative to surgical aortic-valve replacement in the treatment of symptomatic severe aortic stenosis, and this procedure requires technical expertise. The aim of this study was to identify prospective studies on TAVI from the past 10 years, and then to analyze the quality of information reported about the learning curve.Materials and methodsA systematic review of articles published between 2007 and 2017 was performed using PubMed and the EMBASE database. Prospective studies regarding TAVI were included. The quality of information reported about the learning curve was evaluated using the following criteria: mention of the learning curve, the description of a roll-in phase, the involvement of a proctor, and the number of patients suggested to maintain skills.ResultsA total of sixty-eight studies met the selection criteria and were suitable for analysis. The learning curve was addressed in approximately half of the articles (n = 37, 54 percent). However, the roll-in period was mentioned by only eight studies (12 percent) and with very few details. Furthermore, a proctorship was disclosed in three articles (4 percent) whereas twenty-five studies (37 percent) included authors that were proctors for manufacturers of TAVI.ConclusionMany prospective studies on TAVI over the past 10 years mention learning curves as a core component of successful TAVI procedures. However, the quality of information reported about the learning curve is relatively poor, and uniform guidance on how to properly assess the learning curve is still missing.


2011 ◽  
Vol 39 (6) ◽  
pp. 853-860 ◽  
Author(s):  
Olaf Wendler ◽  
Thomas Walther ◽  
Holger Schroefel ◽  
Rüdiger Lange ◽  
Hendrik Treede ◽  
...  

2007 ◽  
Vol 32 (1) ◽  
pp. 188-188
Author(s):  
Dimitri Kalavrouziotis ◽  
Karen J. Buth ◽  
Jean-Francois Legare

2019 ◽  
Vol 22 (2) ◽  
pp. E134-E139 ◽  
Author(s):  
Giuseppe D’Ancona ◽  
Huesyin Ince ◽  
Christoph Raspé ◽  
Alper Öner ◽  
Evren Caglayan ◽  
...  

Background: We present our initial institutional experience with transaortic (TAo) transcatheter aortic valve implantation (TAVI) using a self-expanding aortic bioprosthesis. Methods: A total of 106 patients underwent TAo TAVI with Medtronic CoreValve through a small partial upper sternotomy. We focus our analysis on the overall perioperative results, procedural learning curve (first 30 patients), and midterm follow-up outcomes. Results: VARC-2 device success was achieved in 95 patients (89%), and there were no intraoperative deaths. Nine patients (8.4%) required a second valve and conversion to standard surgery was required in 2 patients (1.8%). The final aortic insufficiency was grade 0 in 65 patients (62%) and grade 1 in 39 (37%). Although patients treated in the TAo TAVI learning phase required a significantly longer radiation time and contrast agent use, device success (93.4% versus 88.2%; P = .7) and prostheses hemodynamics were similar. All-cause mortality at 30 days was 12% (13/106). At a median follow-up of 392 days (IQR: 216-494 days) estimated overall 1-year survival was 72%. No significant differences were reported in terms of 30-day and 1-year observed mortality, and estimated 1-year survival in the learning and later phase of TAo TAVI. Conclusion: TAo TAVI can be performed safely even in the very early phase of the learning curve. Although satisfactory results can be achieved from the beginning, a significant reduction in contrast agent use and radiological exposure are expected as the technique is mastered. Good hemodynamics have been documented and should be further improved with modifications achieved in the TAVI self-expandable valves technology.


2018 ◽  
Vol 13 (3) ◽  
pp. 145 ◽  
Author(s):  
Pavel Overtchouk ◽  
Thomas Modine ◽  
◽  

Transcatheter aortic valve implantation (TAVI) is currently performed through an alternative access in 15 % of patients. The transapical access is progressively being abandoned as a result of its invasiveness and poor outcomes. Existing data does not allow TAVI operators to favour one access over another — between transcarotid, trans-subclavian and transaortic — because all have specific strengths and weaknesses. The percutaneous trans-subclavian access might become the main surgery-free alternative access, although further research is needed regarding its safety. Moreover, the difficult learning curve might compromise its adoption. The transcaval access is at an experimental stage and requires the development of dedicated cavo-aortic crossing techniques and closure devices.


2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
M. Pasic ◽  
A. Unbehaun ◽  
S. Dreysse ◽  
S. Buz ◽  
T. Drews ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document